PDF Patients Receiving Digoxin (Lanoxin) Potential Nursing Diagnoses
Nursing Process Focus:
Patients Receiving Digoxin (Lanoxin)
Assessment
Potential Nursing Diagnoses
Prior to administration:
? Tissue perfusion, Ineffective related to
? Assess for shortness of breath,
decreased cardiac contractility
peripheral edema, pulmonary edema ? Fluid volume, Excess related to inadequate
(initially and throughout therapy)
drug therapy
? Obtain complete medical history
? Knowledge deficient, related to drug action
including allergies, especially cardiac,
and side effects
hypertensive, liver, hematological,
pulmonary diseases including blood
studies: CBC with differential for blood
dyscrasias, liver function tests,
electrolytes, BUN, creatinine, arterial
blood gases. Planning: Patient Goals and Expected Outcomes
The patient will:
? Experience relief of symptoms related to fluid overload.
? Demonstrate evidence of improved organ perfusion, including kidney, heart and brain.
? Demonstrate expected outcomes of drug therapy and list reportable side effects
Implementation
Interventions and (Rationales)
Patient Education/Discharge Planning
? Observe for side effects such as nausea, ? Instruct patient to signs and symptoms of
vomiting, diarrhea, anorexia, shortness of
side effects and to report side effects to
breath, vision changes, leg muscle cramps
health care provider
? Monitor apical-radial pulse for a full
Instruct patient to:
minute prior to every administration of
? Count pulse for a full minute and record
medication. Monitor ECG for rate and
pulse with every doe.
rhythm changes during initial digitalization ? Contact prescriber if pulse rate is less than
therapy. (Serious cardiac dysrthymias may
60 or greater than 100.
occur during initial therapy.)
? Report changes in cardiac rhythm
? Monitor patient's cardiac rhythm. (If given ? Instruct patient to report pulse findings and
for atrial fibrillation, report pulse below 60
rhythm irregularities to health care
or above 110, skipped beats or change if
provider.
rhythm to health care provider.)
? Weigh patient daily. (Weight increase or ? Instruct patient to report weight gain of 2
decrease is an indicator of worsening or
lb. per day.
improvement of medical condition.)
? Monitor serum drug level to determine
? Instruct patient to report to laboratory as
therapeutic concentration and toxicity.
scheduled by health care provider as
Report serum drug levels > 1.8 to health
directed and for ongoing drug level
care provider.
determinations.
? Monitor levels of potassium, magnesium Instruct patient to:
and calcium, BUN, creatinine. (Impaired ? Report changes in urinary output
renal function may contribute to drug
? Keep appointment for followup lab studies
toxicity.)
? Monitor for signs and symptoms of digoxin ? Instruct patient to immediately report
toxicity. (There is a narrow margin of drug
visual changes, mental depression,
levels.)
palpitations, weakness, and loss of appetite,
vomiting and diarrhea. Evaluation of Outcome Criteria
Evaluate the effectiveness of drug therapy by confirming that the patient goals and expected
outcomes have been met (see "Planning").
Nursing Process Focus:
Patients Receiving Lisinopril (Prinivil, Zestoric)
Assessment
Potential Nursing Diagnoses
Prior to administration:
? Fluid volume, Excess related to disease
? Assess for excessive sweating, s/s of
process
dehydration, edema of lower extremities, ? Fluid volume, deficit related to effects of
diarrhea, vomiting (initially and
drug therapy
thoroughout therapy) ? Obtain complete medical history including
allergies, especially renal, thyroid disease, salt restricted diet, use of diuretic, severe salt/volume depletion, coronary insufficiency, leukemia : CBC with
? Injury, Risk for related to hypotension ? Protection, Ineffective, related to
agranulocytosis or neutropenia ? Knowledge Deficient, related to drug
action and side effects
differential, BUN/creatinine, electrolytes,
serum/urine protein, glucose
? Obtain patient's drug history to determine
possible drug interactions and allergies. Planning: Patient Goals and Expected Outcomes
The patient will:
? Demonstrate relief of dyspnea
? Demonstrate an increase in activity tolerance
? Maintain a decrease in peripheral edema
? Exhibit expected outcome of drug therapy and list reportable side effects
Implementation
Interventions and (Rationales)
Patient Education/Discharge Planning
? Observe for side effects such as orthostatic ? Instruct patient to report: persistent, dry
hypotension, persistent, dry irritating
cough; indications of infections; swelling
cough, swelling of face, eyes, lips, tongue,
of face, mouth; difficulty breathing;
arms or legs, difficulty breathing or
headache, dizziness; nausea, vomiting,
swallowing, syncope, fever, sore throat and diarrhea.
hoarseness. Report immediately
? Use with caution in patients with salt or ? Instruct patient to report changes in urinary
volume deficit, or renal disease (may lead
output.
to increased drug levels).
? Use with caution in patients taking
? Inform patient of importance to report all
potassium supplements, potassium sparing
medication including OTC and herbal
diuretics or lithium. (May cause
supplements
hyperkalemia)
? Monitor serum levels of lithium if patient is ? Instruct patient that ACE inhibitor may
receiving lithium.
increase serum level of lithium.
? Monitor for effectiveness of drug. (A
? Inform patient of signs and symptoms of
decrease in dyspnea, edema or jugular
positive therapeutic effect.
distention indicate improvement in medical
condition.)
? Observe for dizziness during first few days of therapy. (May cause drop in blood pressure, especially with diuretic therapy).
Instruct patient to: ? Avoid driving or operating dangerous
machinery until effects of drug are known ? Change positions slowly to prevent injury
Evaluation of Outcome Criteria
Evaluate the effectiveness of drug therapy by confirming that patient goals and expected outcomes have been met (see "Planning").
Nursing Process Focus:
Patients Receiving Isosorbide Dinitrite (Isordil, Sorbitrate, Dilatrate)
Assessment
Potential Nursing Diagnoses
Prior to administration:
? Activity intolerance related to
? Assess for tachycardia, dyrhythmias,
compromised oxygen transport system
reduced exercise intolerance, dyspnea,
? Fatigue secondary to cardiac failure
orthopnea, paroxysmal nocturnal dyspnea, ? Knowledge deficient of self-care program
peripheral edema, and weight gain
related to nonacceptance of lifestyle
(initially and throughout therapy)
modifications
? Obtain complete medical history including ? Pain related to headache
allergies, especially coronary artery
disease, rheumatic heart disease,
pregnancy, impaired renal function, CVA
diseases including blood studies: CBC
with diff, ANA titers, electrolytes, renal
functions, and urinalysis.
? Obtain patient's drug history to determine
possible drug interactions and allergies Planning: Patient Goals and Expected Outcomes
The patient will:
? Exhibit an increase in activity tolerance
? Demonstrate decrease in shortness of breath related to activity
? Maintain a normal blood pressure
? Demonstrate expected outcomes of drug therapy and list reportable side effects. Implementation
Interventions and (Rationales)
Patient Education/Discharge Planning
? Check other medications taken because
? Instruct patient to report all drugs taken.
Isosorbide Dinitrite is contraindicated if
patient is taking sildenafil. (If drug is taken
serious and potentially fatal hypotension
may result.)
? Observe for side effects such as blurred Instruct patient to:
vision, dryness of mouth, hypotension,
? Report side effects.
lupus-like reaction (fever, facial rash,
? Avoid alcohol while taking this drug.
muscle and joint aches, enlarged liver), anorexia, peripheral edema of hands and feet, bluish-color lips, fingernails, and/or palms of hands, headache, shortness of breath, weak and slow heartbeat. Report immediately.
? Rise and change position slowly. ? Record the pulse daily and notify health
care provider if pulse is 20 or > beats per minute. ? Report any weight gain 2lbs or >. ? To decrease nausea, take unsalted crackers
as needed.
? Use cautiously in head trauma or cerebral ? Instruct patient to report changes in
hemorrhage. (May put patient at high risk
sensorium, symptoms of stroke to the
for reduced blood flow to vital organs.)
health care provider.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- pdf what does it mean to take ownership of your career 7 key
- pdf why people don t develop effective corrective actions
- pdf patients receiving digoxin lanoxin potential nursing diagnoses
- pdf why employees do not follow procedures inter
- pdf part 3 advocacy taking action for the human rights of
- pdf a climate action 6 billion why it matters in
- pdf reporting documenting client care
- pdf the importance of data based decision making
- pdf physical therapists in the icu the why what and how of
- pdf reflection importance theory and practice
Related searches
- cities receiving cares act funding
- blood type receiving chart
- package receiving software
- package receiving and tracking systems
- most common diagnoses in america
- dsm 5 diagnoses and codes sheet
- can you work after receiving social security
- why receiving a scholarship is important
- when to start receiving retirement benefits
- common diagnoses in the elderly
- medical surgical nursing pdf download
- sms receiving service